Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Queensland Health
Chubb
McKesson
Cipla
UBS
Johnson and Johnson
Teva
Fish and Richardson
Medtronic

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,299,298

« Back to Dashboard

Which drugs does patent 8,299,298 protect, and when does it expire?

Patent 8,299,298 protects AURYXIA and is included in one NDA.

This patent has seventy-two patent family members in twenty countries.
Summary for Patent: 8,299,298
Title:Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same
Abstract: The present invention discloses pharmaceutical-grade ferric organic compounds, including ferric citrate, which are soluble over a wider range of pH, and which have a large active surface area. A manufacturing and quality control process for making a pharmaceutical-grade ferric citrate that consistently complies with the established Manufacture Release Specification is also disclosed. The pharmaceutical-grade ferric organic compounds are suitable for treating disorders characterized by elevated serum phosphate levels.
Inventor(s): Chan; Keith (Rockville, MD), Town; Winston (Hong Kong, CN)
Assignee: Globoasia, LLC (Rockville, MD)
Application Number:13/289,048
Patent Claim Types:
see list of patent claims
Composition; Formulation; Dosage form;

Drugs Protected by US Patent 8,299,298

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Keryx Biopharms AURYXIA ferric citrate TABLET;ORAL 205874-001 Sep 5, 2014 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 8,299,298

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,754,257 Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same ➤ Subscribe
9,750,715 Method of reversing, preventing, delaying or stabilizing soft tissue calcification ➤ Subscribe
7,767,851 Ferric organic compounds, uses thereof and methods of making same ➤ Subscribe
8,901,349 Ferric organic compounds, uses thereof and methods of making same ➤ Subscribe
9,757,416 Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same ➤ Subscribe
8,093,423 Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same ➤ Subscribe
8,754,258 Ferric organic compounds, uses thereof and methods of making same ➤ Subscribe
8,609,896 Ferric organic compounds, uses thereof and methods of making same ➤ Subscribe
8,338,642 Ferric organic compounds, uses thereof and methods of making same ➤ Subscribe
9,328,133 Ferric organic compounds, uses thereof and methods of making same ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 8,299,298

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Taiwan I375555 ➤ Subscribe
Taiwan 200740431 ➤ Subscribe
Taiwan I335218 ➤ Subscribe
Taiwan 200416027 ➤ Subscribe
Slovenia 1601680 ➤ Subscribe
Portugal 1601680 ➤ Subscribe
New Zealand 566743 ➤ Subscribe
New Zealand 541991 ➤ Subscribe
Malaysia 162727 ➤ Subscribe
Mexico 2008002360 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Deloitte
Express Scripts
Citi
Fuji
Mallinckrodt
Farmers Insurance
Colorcon
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot